Marksans Pharma shares gain 4.5% after subsidiary’s New York facility gets EIR from USFDA

Marksans Pharma Share Price | The USFDA conducted the good manufacturing practices (GMP) inspection at the facility from April 16, 2025, to April 24, 2025.

Leave a Reply

Your email address will not be published. Required fields are marked *